W. Zeller

发表

Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells

J. Topaly, W. Zeller, S. Fruehauf, 2001, Leukemia.

Granulocytes harvested following G-CSF-enhanced leukocyte recovery retain their functional capacity during in vitro culture for 72 hours.

W. Zeller, S. Fruehauf, R. Haas, 1996, Journal of hematotherapy.

Imatinib restores expression of CD62L in BCR‐ABL‐positive cells

P. Paschka, A. Ho, H. Gschaidmeier, 2003, Journal of leukocyte biology.

Differential expression of a recombinant adeno-associated virus 2 vector in human CD34+ cells and breast cancer cells

B. Schiedlmeier, J. Kleinschmidt, W. Zeller, 2000, Cancer Gene Therapy.

Transfer of drug resistance genes in hematopoietic progenitors for chemoprotection: is it still an option?

E. Buss, W. Zeller, S. Fruehauf, 2003, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Protection of hematopoietic stem cells from chemotherapy-induced toxicity by multidrug-resistance 1 gene transfer.

E. Buss, P. Hundsdoerfer, W. Zeller, 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Human-mouse xenografts in stem cell research.

W. Zeller, S. Fruehauf, R. Haas, 1996, Journal of hematotherapy.

Gene Therapy for Sarcoma

N. Kröger, S. Hegewisch-Becker, U. Hengge, 2002, Cells Tissues Organs.

Retroviral MDR1 gene transfer into marrow-engrafting human peripheral blood progenitor cells results in preferential transgene expression in the immature myeloid compartment rather than in mature myeloid progeny in vivo.

E. Buss, S. Naundorf, W. Zeller, 2006, Cytotherapy.

Relevance of Peripheral Blood Progenitor Cell Counts during Steady-State Hematopoiesis to Estimate the Number of Progenitor Cells Mobilized following Granulocyte Colony-Stimulating Factor-Supported Chemotherapy

B. Schiedlmeier, W. Zeller, S. Fruehauf, 1999, Transfusion Medicine and Hemotherapy.

Comparison of Different Lymphoma Cell Purging Modalities: An Experimental Study with K422 Lymphoma Cells

W. Zeller, S. Fruehauf, P. Hundsdörfer, 1999, Acta Haematologica.

Superior gene transfer into solid tumour cells than into human mobilised peripheral blood progenitor cells using helpervirus-free adeno-associated viral vector stocks.

J. Kleinschmidt, B. Schiedlmeier, W. Zeller, 1999, European journal of cancer.

Protection of hematopoietic cells from chemotherapy-induced toxicity by multidrug resistance-I gene transfer followed by analysis of retroviral insertion sites into the human genome

E. Buss, S. Naundorf, W. Zeller, 2003 .

Retroviral transfer of the human multidrug resistance-1 gene in human mobilized peripheral blood progenitor cells engrafting in NOD / SCID mice can confer chemoprotection

E. Buss, B. Schiedlmeier, C. Baum, 2002 .

Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells

W. Ostertag, M. Hildinger, B. Schiedlmeier, 2001, Gene Therapy.

F2A sequence linking MGMTP140K and MDR1 in a bicistronic lentiviral vector enables efficient chemoprotection of haematopoietic stem cells

D. Heckmann, H. Allgayer, F. Wenz, 2012, Cancer Gene Therapy.

Clonal inventory screens uncover monoclonality following serial transplantation of MGMT P140K-transduced stem cells and dose-intense chemotherapy.

C. von Kalle, H. Allgayer, I. Roeder, 2011, Human gene therapy.

Analysis of self-inactivating lentiviral vector integration sites and flanking gene expression in human peripheral blood progenitor cells after alkylator chemotherapy.

H. Allgayer, F. Wenz, M. Zucknick, 2010, Human gene therapy.

QuickMap: a public tool for large-scale gene therapy vector insertion site mapping and analysis

G Opelz, A Hotz-Wagenblatt, S Fruehauf, 2009, Gene Therapy.

Rapid detection of retroviral vector integration sites in colony-forming human peripheral blood progenitor cells using PCR with arbitrary primers

W. Zeller, S. Fruehauf, B. Gentner, 2003, Gene Therapy.

Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O6-methylguanine-DNA methyltransferaseP140K

S Fruehauf, F Wenz, F. Wenz, 2010, Gene Therapy.

Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning

A. Ho, J. Topaly, W. Zeller, 2002, British Journal of Cancer.

Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice.

B. Schiedlmeier, C. Baum, W. Zeller, 2000, Blood.

Soluble bone marrow stroma factors improve the efficiency of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells.

E. Buss, B. Schiedlmeier, W. Zeller, 1999, Human gene therapy.

Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functions

A. Zander, A. Ho, A. Hotz-Wagenblatt, 2006, Bone Marrow Transplantation.

Peripheral blood progenitor cell (PBPC) counts during steady‐state haemopoiesis enable the estimation of the yield of mobilized PBPC after granulocyte colony‐stimulating factor supported cytotoxic chemotherapy: an update on 100 patients

A. Ho, A. Benner, J. Topaly, 1999, British journal of haematology.

Human multidrug resistance-1 gene transfer to long-term repopulating human mobilized peripheral blood progenitor cells

B. Schiedlmeier, C. Baum, W. Zeller, 2000, Bone Marrow Transplantation.

Combination therapy with imatinib mesylate (sti571): synopsis of in vitro studies

J. Topaly, W. Zeller, S. Fruehauf, 2002, British journal of haematology.

Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL – Inhibition of P-glycoprotein function by 17-AAG

S Fruehauf, A. Jauch, J. Melo, 2005, Leukemia.

Prospects and RISC score of viral gene therapy for sarcoma

W. Zeller, S. Fruehauf, M. Veldwijk, 2003, Expert opinion on biological therapy.

Delineation of Cell Cycle State and Correlation to Adhesion Molecule Expression of Human CD34+ Cells from Steady‐State Bone Marrow and Peripheral Blood Mobilized Following G‐CSF‐Supported Chemotherapy

W. Zeller, S. Fruehauf, R. Haas, 1998, Stem cells.

CD34 selection for purging in multiple myeloma and analysis of CD34+ b cell precursors

W. Zeller, S. Fruehauf, R. Haas, 1994, Stem cells.

Clonal Analysis of Individual Marrow‐Repopulating Cells after Experimental Peripheral Blood Progenitor Cell Transplantation

E. Buss, S. Naundorf, J. Topaly, 2004, Stem cells.

Multiple Displacement Ampliﬁcation Enables Large-Scale Clonal Analysis following Retroviral Gene Therapy (cid:1)

H. Allgayer, F. Wenz, P. Maier, 2008 .

Multiple Displacement Amplification Enables Large-Scale Clonal Analysis following Retroviral Gene Therapy

H. Allgayer, F. Wenz, W. Zeller, 2007, Journal of Virology.

Susceptibility of mesothelioma cell lines to adeno-associated virus 2 vector-based suicide gene therapy.

A. Jauch, F. Wenz, W. Zeller, 2004, Lung cancer.

Increased poly(ADP-ribosyl)ation in intact cells by cisplatin treatment.

A. Bürkle, W. Zeller, J. Küpper, 1993, Carcinogenesis.

Multidrug resistance 1 gene transfer can confer chemoprotection to human peripheral blood progenitor cells engrafted in immunodeficient mice.

C. Baum, W. Zeller, S. Fruehauf, 2002, Human gene therapy.